chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 102 degrees; Chills/rigors; Fatigue; Headache; Body aches; Injection site redness; Injection site pain; Injection site swelling; This is a spontaneous report from a contactable healthcare professional. A 50-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EL9262, via an unspecified route of administration at left arm on 22Jan2021 13:00 at a single dose for COVID-19 immunisation. Medical history included allergy to metals, cervix carcinoma from 2014, hysterectomy from 2014, chemotherapy from 2014, radiotherapy from 2014, Lyme disease from 1991 and mononucleosis from 1980's. Concomitant medication included bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]). The patient previously took codeine and experienced allergy. Historical vaccine included first dose of bnt162b2 on 22Dec2020. On 23Jan2021, the patient experienced fever of 102 degrees, chills, rigors, fatigue, headache, body aches, injection site redness, injection site pain and injection site swelling. The patient took ibuprofen as rest as treatment. The outcome of the events was recovering.
This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle ache at the right side of her body) and PAIN IN EXTREMITY (A little sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (Muscle ache at the right side of her body) and PAIN IN EXTREMITY (A little sore arm). At the time of the report, MYALGIA (Muscle ache at the right side of her body) and PAIN IN EXTREMITY (A little sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
I?m having sore muscles, joints pain, headache, reduced tasting, fatigue, nose congestion, sore throat, heavy chest, and facial swelling. It?s been like this since I got my shot.
I had fever 101.5 body ache chills malaise and fatigue they were all moderate, I could not work and that lasted 24 hours post vaccine and continued to 48 hours and got better and after 48 hours I just had a headache, fever and chills improved I just had a worse headache and I did a virtual urgent care visit on 12/18/2020 and didn't prescribe anything. I refused to take any  medication. 12/19/2020 right now I have a moderate headache . I don't have  fever anymore and can function.
Adverse events: We can't refuse to take the ANTHRAX vaccine. Symptoms: joint pain, headaches, muscle aches, temporary memory loss and flu. (There are no diagnosis, no treatment). Received the ANTHRAX vaccine against disease and bioterror threats, three times. The first vaccine was on March 1991. Several days after I received the first shot I experience side effects such as muscle aches, joint pain, digestive problem, headaches, and chills. After be vaccinate, personnel who administered vaccine, refused to sign my vaccine records. For these reason I do not have have any evidence of such treatment.
She had a cough, congestion, fever, and a runny nose. She still is having these symptoms at this time. She was not prescribed any medications. She also got a rash on her torso that looked kind of like pimples. She does not have the rash at this time and I'm not sure if it is related.
The vaccine was found expired by cold chain, and even so was applied at a 9:30 am appointment. At 12:49 they contacted us to inform us of what happened and once again coordinated the application of the vaccine since the first one had no effect.   After asking for the necessary clarifications and with fear, I decided again to get vaccinated In the vaccination card I kept the annotation of what had occurred.
5.5cm erythematous and blistered area at injection site. Warm to touch.
Breakthrough case admission after 2 vaccines  Moderna 3/29/21 Lot# 026B21A;  Moderna 4/26/21 Lot# 002C21A
Felt like I was getting the flu, chills, temperature of 100.8 degree. Soreness in the arm where the shot was given.  Slight upset stomach.  I used 2 ibuprofen after symptoms started and 2 more 8 hours later.  Incident and temperature stated at 11am and temperature went away about 11:30pm.
This spontaneous report was received from a 86 year old female patient regarding herself. No medical history was reported. On an unknown date approximately in March 2003 (reported as 10 years ago), the patient was vaccinated with a dose of ZOSTAVAX (lot #, dose, route not reported). No concomitant medications were reported. On an unknown date approximately in March 2013, the patient developed shingles. The patient stated that she also developed a sore round place above her hip that has now spread around to her back. The outcome of shingles and sore round place above her hip that has now spread around to her back was unknown. The causality for the events with ZOSTAVAX was unknown. Additional information has been requested.
1/1/2022 Runny nose, sneezing, headache, body aches, temperature 101 deg. 1 Tylenol for arthritis 650 mg, reduced temp and pain. 1/2/2022 Same as the previous day plus scratchy throat, some dry coughing. 1 Tylenol for arthritis 650 mg, reduced temp and pain. 1/3/2022 Less runny nose, sore throat, some dry coughing, headache, body aches, temp 101 deg. 1 Tylenol for arthritis 650 mg, reduced temp and pain. 1/4/2022 Same as the previous day 1/5/2022 All symptoms moderating 1/6/2022 Same as the previous day. Saw physician 1/7/2022 Continued improvement. Very mild syptoms.
Significant rash over entire body, (torso, arms, legs, back). I am debating whether to go to emergency clinic or see my doctor. Other initial site effects (fever, chills, etc) have dissipated as of this morning.
Around family members who had COVID-19. Took a home and a PCR test, both were negative. Two days later tested positive for COVID-19.
Feels like she was run over by a truck; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer. An adult female patient (unknown if pregnant) received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown, whether the patient received any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first and second doses of COVID-19 VACCINE (MANUFACTURER UNKNOWN; Lot Number: UNKNOWN);  both on unknown dates for COVID-19 immunisation. On 05Nov2021, after the patient received the third dose, she felt like "she was run over by a truck." The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of "felt like she was run over by a truck" was resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
bumps on arm, stomach and back; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (bumps on arm, stomach and back) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced SKIN REACTION (bumps on arm, stomach and back). At the time of the report, SKIN REACTION (bumps on arm, stomach and back) outcome was unknown.            No Concomitant medication were reported. Treatment medication was not provided.
A  short time after getting the Johnson vaccine I was diagnosed with blood clots in my lower left leg.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose the prevention of shingles (herpes zoster). The patient suffered painful sensations of burning, tingling and sudden sharp localized pain. As a result of her symptoms, the patient presented to a medical provider and was ultimately diagnosed with internal shingles. The patient has also experienced mental and emotional distress due to resulting physical limitations and the seriousness of her condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. Internal shingles was considered disabling. Additional information has been requested.
Mom states that pt had cracked lips 4 days after vaccination.  The whole lips became swollen and had blisters which peeled.  They saw their physician on 8/11/09 who called an allergist.  The allergist stated that this was an allergic reaction to the MCV4 vaccine and that she should never receive this vaccine again.
Pt presented 03/20/18, with reports of a reaction to PCV 13 vaccine, given 03/14/18 reports has been getting worse, site: left deltoid, red, warm and raised to about the size of a baseball, soft. Doxycycline 100 mg for 14 days prescribed, Ibuprofen 600 mg three times a day for pain, also recommended, application of ice pack off and on every 2 hours for 24 hours, pt to return in 1 week for re-evaluation.
Moderna COVID Vaccine: COVID-19 case resulting in Hospitalization/Death. Rec'd Moderna Vaccines on 2/26/2021 and 3/26/2021 and Pfizer on 11/26/2021. Presented to ED URI sxs. Admitted for PNA 2/2 Covid c/b resp failure w/hypoxia and lactic acidosis. Tx'd w/remdesivir x5 days, steroids x10 days. Extubated 6/26/22. Continued to struggle with respiratory distress. Developed worsening respiratory status 7/2/22 and started on BiPAP 7/2.  Improvement in pH and pCO2 but developed hypotension and concern for sepsis into 7/3. Broad spectrum antibiotics and pressors initiated. Transitioned to comfort care and expired on 7/4/22 at 1645.
NOT FEELING WELL; SEVERE HEADACHE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced not feeling well, severe headache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe headache, fever, and not feeling well. This report was non-serious.
No adverse event; administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose) and NO ADVERSE EVENT (No adverse event) in a 9-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     HCP did not describe Medical History or Condition.    On 06-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 03-Jul-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .2 milliliter. In 2023, the patient experienced WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose).    Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication not reported.   HCP reported that they administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose. They were supposed to administer the Dark Blue Cap and Label with Gray Border. Patient received 0.2 ml dose of the Dark Pink Cap and Label with Yellow Box as a 1st dose on 06 Jun 2023 and as a 2nd dose on 03 Jul 2023. HCP stated she had initially reported to the CDPH here after the first dose. Patient was 9 months. Patient never received the Dark Blue Cap and Label with Gray Border.   Treatment medication not reported.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 02-APR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml Prefilled Syringe (PFS) (lot # K020795, expiration date 19-MAR-2016, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 64 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
BLOOD CLOTS IN HER LEGS; BLOOD CLOTS IN LUNGS; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 total, dose was not reported, administered on MAR-2021 for prophylactic vaccination (dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  The reporter stated that "My daughter had the vaccine last March now she has blood clots in her legs and in her lung and said she will have to be on Xarelto for the rest of her life". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots in her legs and blood clots in lungs was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220100825-covid-19 vaccine ad26.cov2.s-  Blood clots in her legs ,Blood clots in lungs. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
She thinks some vaccine leaked on her/ Liquid run down my arm; She thinks some vaccine leaked on her; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her). On 23-Feb-2021, UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow up appended, Same reporter with new address and height, weight added and patient enthinic group and race provided
tingling in my throat; tingling on the tongue and bottom lip; Burning sensation in my throat, on the tongue and bottom lip and on the left side of the face as well; tingling sensation developed on the left side of the face; This is a spontaneous report from a non-contactable pharmacist reporting for herself. A 33-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El1283), via an unspecified route of administration on 14Jan2021 at single dose in left arm for COVID-19 immunisation. Patient age at time of vaccination was 33 years. The vaccine was administered in the Clinic. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included migraine very infrequent. Concomitant medications included norethisterone (NORETHINDRONE). The patient had no known allergies. She reported that slightly over 48 hours post injection on 17Jan2021 she developed a tingling and burning sensation in throat, on the tongue and bottom lip. A burning or tingling sensation developed on the left side of the face as well. Treatment for the events included Benadryl. The patient had not recovered from the events at the time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Pt to ED 11/2 for shortness of breath. Pt COVID+ 11/2. 11/3 started on remdesivir & decadron. 11/4 pt left hospital, discharged.
This spontaneous report as received from a vaccine coordinator refers to multiple patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # L027733, expiration date 13-SEP-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 28.4 degrees Fahrenheit for 2 days, 21 hours, 30 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Swelling of arm redness. Severe headache, vomiting diarrhea, burping. Couldn't eat for 3 days, eye pain itching all over body and lips tingling, fatique
Patient became lethargic, vomited then became unresponsive, mom brought her back to office where we could not find a good pulse or BP. So the nurse and I accompanied mom and patient to the ER/where she received IV fluids and IV steroids and slowly improved. Admitted for observation. 11/16/07-records received for DOS 10/16/07-admitted for observation. DX: Unresponsive. After vaccination she became fatigued and had an episode of vomiting and became unresponsive, pale and sweating while in lab of  the physician office. Mom returned her to clinic, she was observed to be blue around mouth, unresponsive and floppy. In ED tachycardic.
Patient's significant other states that on 10/17/18 patient developed a rash that made his right earlobe red and made a line from his earlobe to cheek bone. Patient's significant other stated he put POLYSPORIN on it. RPh recommended Hydrocortisone cream (pt used 0.5%) and cool cloth. On 10/18, patient & significant other stopped by the pharmacy and stated rash had mostly resolved (appeared clear per observation) and that hydrocortisone cream had helped and patient would continue that for a few days.
Information has been received from a nurse practitioner concerning a 13 month old female patient who on 29-JAN-2009 was vaccinated with a 0.5 ml dose of PROQUAD vaccine (Merck). Concomitant therapy included POLY-VI-SOL. It was reported that on approximately 03-FEB-2009, the patient experienced a low grade fever of 99F for 1 day then a high fever of 102F for 2 days. It was reported that the high fever occurred on approximately 04-FEB-2009 about 6 days after administration of PROQUAD vaccine (Merck). It was reported that on approximately 05-FEB-2009, in the last 4 days, the patient developed a macular papular rash all over the body. The patient sought medical attention with an office visit. Additional information has been requested.
no symptoms; an expired dose of VAQTA was administered to a patient; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 15-JUL-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # S018419, expiration date 12-JUL-2020 (dose and route of administration were not reported) for prophylaxis. There was no adverse event reported.
This spontaneous report as received from a nurse refers to a 20 months 7 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) liquid PEDVAXHIB (injection, lot # K016965, exp date: 20-JUL-201)(dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.